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Hedgehog (Hh) signaling regulates cell differentiation and patterning in a wide variety of embryonic tissues. In vertebrates, at least
three Gli transcription factors (Gli1, Gli2, and Gli3) are involved in Hh signal transduction. Comparative studies have revealed divergent
requirements for Gli1 and Gli2 in zebrafish and mouse. Here, we address the question of whether Gli3 function has also diverged in
zebrafish and analyze the regulatory interactions between Hh signaling and Gli activity. We find that zebrafish Gli3 has an early function
as an activator of Hh target genes that overlaps with Gli1 activator function in the ventral neural tube. In vitro reporter analysis shows that
Gli3 cooperates with Gli1 to activate transcription in the presence of high concentrations of Hh. During late somitogenesis stages, Gli3 is
required as a repressor of the Hh response. Gli3 shares this repressor activity with Gli2 in the dorsal spinal cord, hindbrain, and midbrain,
but not in the forebrain. Consistently, zebrafish Gli3 blocks Gli1-mediated activation of a reporter gene in the absence of Hh in vitro. In
the eye, Gli3 is also required for proper ath5 expression and the differentiation of retinal ganglion cells (RGCs). These results reveal a
conserved role for Gli3 in vertebrate development and uncover novel regional functions and regulatory interactions among gli genes.
D 2004 Elsevier Inc. All rights reserved.
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Secreted morphogens of the Hedgehog (Hh) family direct
a wide range of developmental events, from segmentation
and wing patterning in Drosophila to nervous system and
limb patterning in vertebrates (reviewed in Ingham and
McMahon, 2001). In the vertebrate neural tube, evidence0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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morphogen to direct cell fates in a concentration-dependent
manner. Cells closest to the ventral source of Hh adopt
ventral fates, while cells more distant from the Hh source
acquire progressively more dorsal fates (Briscoe and
Ericson, 1999; Ericson et al., 1997; Marti et al., 1995;
Wijgerde et al., 2002).
Members of the Hh family bind to the transmembrane
receptor Patched (Ptc) resulting in the derepression of
another transmembrane protein Smoothened (Smo) that
regulates the activity of Gli family transcription factors
(reviewed in Ingham and McMahon, 2001). In Drosophila,
Hh signaling regulates the function of the single Gli
homolog, Cubitus interruptus (Ci). Ci can either activate or
repress Hh signaling, depending on posttranslational mod-277 (2005) 537–556
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is cleaved to produce an N-terminal repressor isoform that
represses Hh target gene expression. Activation by Hh
suppresses this cleavage, leading to a full-length activator
form of the protein. At least three Gli proteins are found in
vertebrates. In the mouse, these proteins mediate all Hh-
dependent patterning in the neural tube (Bai et al., 2004).
Like Ci, all three vertebrate Gli proteins have five highly
conserved zinc finger DNA binding domains and C-
terminal activation domains, with Gli2 and Gli3 also having
N-terminal repressor domains (Dai et al., 1999; Sasaki
et al., 1999).
Based on genetic and misexpression analyses, complex
overlapping and unique functions for Gli1 and Gli2 have
been shown. Mouse mutant studies have shown that Gli2 is
an Hh-dependent activator of the Hh response in the nervous
system, limbs, and lung and is essential for early develop-
ment (Ding et al., 1998; Matise et al., 1998; Mo et al., 1997;
Motoyama et al., 1998). Mice lacking Gli2 function fail to
form a floor plate and have ventral neural tube defects (Ding
et al., 1998; Matise et al., 1998). While Gli1 is transcrip-
tionally up-regulated by Hh and can activate the HhTable 1
Morpholino injections: repressor roles for Gli3 and Gli2
Probe/assay Injected cross MO-injected Great dorsal
expansion
fkd4, 19 h wt uninjected 0
gli3 [10 ng] 0
gli2 [10 ng] 0
gli2 + 3 [5 + 5] ng 0
lacZ RNA [65 pg] 0
shh RNA [65 pg] 27 (77%)
dtr(gli1)/ uninjected 0
gli3 [10 ng] 0
fkd4, 24 h wt uninjected 0
gli3 [10 ng] 125 (74%)
gli3V[10 ng] 3 (14%)
lacZ RNA [65 pg] 0
shh RNA [65 pg] 25 (83%)
dtr(gli1)/ uninjected 0
gli3 [10 ng] 25 wt (56%)
gli2 + 3 [5 + 5] ng 31 (35%)
syu(shh)/ uninjected 0
gli3 [10 ng] 40 wt (70%)
smu(smo)/ uninjected 0
gli2 [10 ng] 0
gli3 [10 ng] 99 wt (54%)
gli2 + 3 [5 + 5] ng 37 wt (43%)
gli1, 19 h wt uninjected 0
gli3 [12 ng] 0
gli1, 24 h untreated wt uninjected 0
gli3 [9 + 12 ng] 0
100 AM CyA uninjected 0
gli3 [9 + 12 ng] 0
axial, 24 h wt uninjected 0
gli3 [10 ng] 0
smu(smo)/ uninjected 0
gli2 [10 ng] 0
gli2 + 3 [5 + 5] ng 0response, mutant analyses in mouse show that Gli1 is not
required for neural patterning or early development (Park et
al., 2000). However, Gli1 can substitute for Gli2 in mouse
development, indicating overlapping activator roles for
these two Gli proteins (Bai and Joyner, 2001). The situation
is different in zebrafish, where Gli1 is the major activator of
Hh target genes and Gli2 plays both activator and repressor
roles in different regions of the embryo (Karlstrom et al.,
2003). Consistent with these mutant analyses, in vitro
reporter assays and overexpression experiments in frog
embryos also suggest that Gli1 is an activator of Hh targets
genes while Gli2 has both activator and repressor functions
(Aza-Blanc et al., 2000; Mullor et al., 2001; Regl et al.,
2002; Ruiz i Altaba, 1998; Sasaki et al., 1997).
Like Ci, Gli3 can be processed to form a repressor
isoform, and this proteolytic processing is inhibited by Hh
signaling (Litingtung et al., 2002; Wang et al., 2000). Gli3
also functions like Ci as both an activator and repressor of
Hh signaling in vivo. In mouse, it appears that Gli3 is the
only Gli protein that functions as a repressor. This repressor
function is seen in loss-of-function mutants, which have
phenotypes resembling those seen after Shh activation (HuiDorsal expansion Wild-type Mutant
phenotype
Total
0 43 (100%) 0 43
0 30 (100%) 0 30
0 13 (100%) 0 13
0 35 (100%) 0 35
0 34 (100%) 0 34
4 (23%) 0 0 31
0 52 (73%) 19 (27%) 71
0 18 (72%) 7 (28%) 25
0 100 (100%) 0 100
23 (14%) 12 (12%) 0 170
17 (81%) 1 (5%) 0 21
0 35 (100%) 0 35
5 (17%) 0 0 30
0 71 (71%) 29 (29%) 100
2 wt (4%) 10 (22%) 8 (18%) 45
28 (32%) 11 (13%) 17 (20%) 87
0 61 (73%) 23 (27%) 84
7 {wt + mut} (13%) 7 (13%) 2 (4%) 56
0 126 (74%) 45 (26%) 171
15 {mut only} (11%) 97 (68%) 30 (21%) 142
16 {wt only} (9%) 29 (16%) 38 (21%) 182
8 {mut only} (9%) 23 (27%) 18 (21%) 86
0 53 NA 53
0 51 NA 51
0 42 NA 42
81 0 NA 81
0 0 40 (= red. exp.) 40
114 (also red. exp.) 0 0 114
0 52 (100%) 0 52
0 16 (100%) 0 16
0 32 (70%) 14 (30%) 46
10 {1–2cells} (12%) 56 (69%) 15 (19%) 81
2 {1–2 cells} (8%) 17 (65%) 7 (27%) 26
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ventral cell types in the spinal cord (Persson et al., 2002)
and dorsal expansion of ventral telencephalic markers in the
forebrain (Aoto et al., 2002; Grove et al., 1998; Theil et al.,
1999; Tole et al., 2000). This major role as a repressor is
also uncovered by removing Gli3 function in embryos
lacking Shh or Smo function. Removing Gli3 rescues digit
formation and all but the most ventral spinal cord defects
caused by loss of Hh signaling (Litingtung and Chiang,
2000; Rallu et al., 2002; Wijgerde et al., 2002), indicating
that a major role of Hh signaling is to overcome Gli3-
mediated repression of Hh target genes.
Besides this well-documented repressor function, Gli3
can act as a weak activator during spinal cord patterning in
vivo (Bai et al., 2004), consistent with in vitro studies that
indicate Gli3 can activate Hh target gene expression (Dai
et al., 1999; Ruiz i Altaba, 1999; Sasaki et al., 1997; Shin
et al., 1999). Using elegant knockout and knockin
approaches, Bai et al. (2004) showed that Hh-dependent
expression of Gli1 is reduced in Gli3 mutants and
completely absent in Gli3/Gli2 double mutants. This
indicates that Gli3 functions with Gli2 to activate Hh
signaling. In addition, expressing Gli3 in place of Gli2
weakly induces some ventral cell types, confirming a weak
activator function for Gli3 in the ventral spinal cord (Bai et
al., 2004). Activator function for Gli3 is also illustrated by
the fact that Gli3 can contribute to ventral specification,Table 2
Morpholino injections: activator role for Gli3
Probe/assay Injected cross MO-injected smu-like G
r
nk2.2, 19 h,
forebrain
wt uninjected 0
gli3 [10 ng] 0
gli1 + 3 [3 ng + 7 ng] 4 (7%) 4
dtr(gli1/) uninjected 0
gli3 [10 ng] 1 (2%)
gli3V[10 ng] 3 (5%) 1
gli1 + 3 [3 ng + 7 ng] 6 (8%) 3
syu(shh/) uninjected 0
gli3 [10 ng] 0
nk2.1b, 28 h wt, di control [10 ng] 0
gli3 [10 ng] 0
gli2 + 3 [5 ng + 5 ng] 0
dtr(gli1/), di control [10 ng] 0
gli3 [10 ng] 7 (30%)
gli2 + 3 [5 ng + 5 ng] 6 (25%)
ptc1, 11 h,
19 h
wt control [10 ng] 0
gli1 [7 ng – 10 ng] 0
gli3 [10 ng] 0
gli1 + 3 [3 ng + 7 ng] 0 9
dtr(gli1/) uninjected 0
gli1 + 3 [3 + 7 ng] 0 2
Zn-5, 48 h wt uninjected NA
gli3 [10 – 12 ng] NA
ath5, 34 h wt uninjected NA
gli3 [9 ng] NA 1
gli3 [12 ng] NA 2
dtr phenotype is a general reduction in ptc expression and regionally absent expespecially in the rostral neural tube (Motoyama et al.,
2003). While these data confirm that Gli3 mediates Hh
signaling in vivo, little is known about how Gli3 activator
and repressor functions are spatially and temporally
distributed, and how Gli3 functions with Gli1 and Gli2
to pattern the embryo.
Studies of Gli3 activator and repressor function are
particularly important because mutations in human Gli3
lead to a variety of diseases including Greig cephalopo-
lysyndactyly syndrome (GCPS) (Kalff-Suske et al., 1999;
Vortkamp et al., 1991; Wild et al., 1997), Pallister-Hall
syndrome (PHS) (Kang et al., 1997), and postaxial
polydactyly type A (PAP-A) (Radhakrishna et al., 1997).
These human diseases are the result of Gli3 truncations,
point mutations, and frame shifts. While no clear
genotype–phenotype correlation has been uncovered
(Ming and Muenke, 2002), the fact that polydactyly is
caused by all of these mutations points to a major
repressor role for human Gli3, at least in the developing
limb.
The studies on Gli3 function have raised two major
questions. First, previous studies have shown that the
requirements for Gli1 and Gli2 have diverged between
zebrafish and mouse. We therefore asked whether the role
of Gli3 has also diverged or been conserved in zebrafish.
Second, the regulatory interactions between Hh signaling
and gli genes are still unclear. We have therefore used thereatly
educed
dtr-like Generally
reduced
Wild-type Total
0 0 0 54 (100%) 54
0 0 20 (77%) 6 (23%) 26
0 (73%) 9 (16%) 1 (2%) 1 (2%) 55
0 16 (33%) 0 33 (67%) 49
7 (17%) 3 (7%) 20 (47%) 11 (27%) 41
0 (18%) 9 (16%) 10 (18%) 24 (43%) 56
9 (50%) 26 (33%) 4 (5%) 3 (4%) 78
0 13 (syu-like) (36%) 0 23 (64%) 36
9 (20%) 0 0 36 (80%) 45
0 0 0 40 (100%) 40
0 0 44 (86%) 7 (14%) 51
0 0 9 (45%) 11 (55%) 20
0 8 (24%) 0 25 (76%) 33
0 10 (43.6%) 6 (26%) 1 (0.4%) 23
0 12 (50%) 6 (25%) 0 24
0 0 0 90 (100%) 90
0 83 (90%) 0 9 (10%) 92
0 0 62 (770%) 19 (23%) 81
3 (74%) 33 (26%) 0 0 126
0 32 (24%) 0 99 (76%) 131
5 (25%) 40 (40%) 16 (15%) 20 (20%) 101
0 NA 0 20 (100%) 20
5 (25%) NA 8 (40%) 7 (35%) 20
0 NA 0 50 (100%) 50
5 (27%) NA 28 (50%) 13 (23%) 56
7 (61%) NA 13 (30%) 4 (9%) 44
ression of nk2.2 and nk2.1b.
O.V. Tyurina et al. / Developmental Biology 277 (2005) 537–556540powerful genetics of the zebrafish system to clarify these
relationships. We characterize zebrafish gli3 and demon-
strate that Gli3 plays both activator and repressor roles
during different phases of zebrafish embryonic develop-Fig. 1. Zebrafish Gli3 sequence analysis. (A) Amino acid sequence of zebrafish Gli
CLUSTALW alignment program. Conserved amino acids are in blue. Black lines i
domains (97% identity). An N-terminal repressor domain sequence (Sasaki et al.,
sequence (Dai et al., 1999) is contained between dAT arrows. (B) Cladogram sh
alignment of amino acid sequences. (C) Schematic representation of mGli3, zfGli3
acids long with 80% and higher identity between zfGli3 and mGli3. Red boxes in
boxes show regions with greater than 80% identity and include the zinc finger do
available in Genbank, submission no. AY377429. ment. In the early stages of CNS dorsal/ventral patterning,
Gli3 function overlaps with Gli1 function to activate the
Hh response. In the developing eye, Gli3 appears to be the
primary activator of Hh-mediated retinal ganglion cell3 (zfGli3) aligned with mouse Gli3 (mGli3) and Xenopus Gli3 (xGli3) using
ndicate homology domains that include highly conserved zinc finger (ZnFn
1999) is contained between dRT arrowheads. A C-terminal activator domain
owing similarity of vertebrate Gli sequences. Tree is based on ClustalW
, zfGli2, and zfGli1. Blue boxes indicate sequences of more than 20-amino
dicate similar conserved regions between zfGli3, mGli3, and zfGli2. Green
mains. Brackets indicate activator and repressor domains. Gli3 sequence is)
-
Fig. 1 (continued).
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zebrafish Gli3 acquires a tissue- and target-specific
repressor function that blocks the Hh response in the
dorsal spinal cord and caudal brain. Our in vivo data help
define how overlapping and distinct Gli1, Gli2, and Gli3
functions combine to integrate Hh signals.Materials and methods
Cloning and mapping zebrafish gli3
We obtained a partial zebrafish gli3 cDNA (containing the
zinc finger and 3V regions) by screening a 15- to 19-h
embryonic cDNA library (gift of B. Appel and J. Eisen) using
a radio-labeled mouse Gli2 probe and low stringency
hybridization conditions. A 5VRACE reaction (Invitrogen)
identified cDNA fragments encoding the 5V portion of
zebrafish gli3. cDNA fragments were assembled to give the
full Gli3-coding region that was sequenced using the UMass
sequencing facility (Genbank accession no. AY377429).
Sequence was subsequently verified by comparison to
genomic sequence from the zebrafish genome project
(Sanger Center: http://www.sanger.AC.uk/Projects/D_rerio/
). Genomic clones containing zebrafish gli genes were
obtained by screening a gridded genomic bacterial artificial
chromosome (BAC) library (Genome Systems) using a Gli2
probe (Karlstrom et al., 1999, 2003). gli3-containing BACs
were then identified using gli3-specific PCR primers
designed using cDNA sequence. These primers were then
used to characterize four gli3-positive BACs (b156g24,
b155o03, b51e17, and 164J21) and obtain genomic
sequence. Subsequent PCR analysis indicated that none of
the identified BACs contained the 5Vend of the gli3 cDNA.
A single-strand conformation polymorphism (SSCP) was
identified for SP6 end sequence derived from BAC 164J21,
and this polymorphic fragment was used to map gli3 to
zebrafish linkage group 24 (genetic map of region can be
viewed at http://zfin.org).PCR genotyping dtr(gli1) fish
Embryos of dtrts269 mutant clutch were genotyped as
described in Karlstrom et al. (2003). Primer sequences were
ts269Mu.rv: 5V-TGGGATCATGTTGCCCA and dtr8.fw: 5V-
GTCTAAAGGCTAAATATGCAGC.
In situ hybridization
The in situ labelingwas performed as previously described
(Karlstrom et al., 2003). Probes used were nk2.2 (Barth and
Wilson, 1995), nk2.1b (Rohr et al., 2001), fkd4 (Odenthal and
Nusslein-Volhard, 1998), axial (fkd1)(Odenthal and Nus-
slein-Volhard, 1998; Strahle et al., 1993), ptc1 (Maeda et al.,
1993), shh (Krauss et al., 1993), and ath5 (Masai et al., 2000).
gli3 probe was synthesized using T7 RNA polymerase from a
gli3/pBluescript plasmid linearized with Not1. For double
gli3/shh in situ staining, a fluorescein-labeled shh probe was
used together with digoxygenin-labeled gli3 probe. After
incubation in an alkaline phosphatase-conjugated anti-digox-
ygenin antibody, embryos were labeled using the NBT
substrate and fixed overnight. Embryos were then washed
in PTw (PBS + 0.1% Tween 20) for 1 h, blocked as
previously, and incubated in anti-fluorescein antibodies
overnight at 48C. After washing in PTw for 2 h and
equilibration in 0.1 M Tris buffer (pH 9.5, 0.05 M MgCl2,
0.1MNaCl), a second color reaction was performed using the
INT substrate as described in manufacturer’s instructions
(Roche).
Antibody labeling
Embryos injected with gli3 morpholino (MO) and
control MOs were grown to the 40-h stage, fixed in 4%
paraformaldehyde for 30 min, and dehydrated in meth-
anol for 30 min at room temperature. After rehydration
in PTx (PBS + 0.1% Triton X-100), embryos were
stained with the ZN-5 antibody as described in Karlstrom
et al. (1996). After washing, embryos were incubated
O.V. Tyurina et al. / Developmental Biology 277 (2005) 537–556542with secondary FITC-conjugated goat anti-mouse anti-
bodies (1:200 dilution) overnight at 48C, washed in PTx,
cleared in 75% glycerol, and visualized using a Zeiss
confocal microscope.
mRNA and morpholino antisense oligonucleotide injections
Embryos were pressure-injected as described in
Karlstrom et al. (2003). zfgli1 (5V-CCGACACACCC-
GCTACACCCACAGT), zfgli2 (5V-GGATGATGTA-
AAGTTCGTCAGTTGC) and two nonoverlapping zfgli3
morpholino antisense oligos (5V-ACAACTGGGCATTCCT-
CAGAGCATC and 5V-GACAGGATACTCGTTGTTGT-
GAAAC), and a random control oligo (5V-CCTCTTA-
CCTCAGTTACAATTTATA) were synthesized by Gene
Tools (Eugene, OR) and kept as 25 mg/ml stocks in 1
Danio solution (Westerfield, 1993). Three to twelve nano-
grams of different MOs or MO combinations were injected at
the two-cell stage, and embryos were grown to the desired
time points when they were fixed for in situ or antibody
labeling (see Tables 1 and 2). At the higher concentrations,
injection of gli3MOs led to convergence extension defects in
5–15% of embryos. Only embryos showing normal mor-
phology were assayed for effects on CNS development.
Embryonic phenotypes in gli1-, gli3-, and gli1+gli3 MO-
injected embryos were scored by three different members of
the laboratory without knowledge of the experimental
manipulation. Sorting of embryos based on ptc1 expression
levels was nearly identical in all three cases and corresponds
to the results shown in Fig. 5.
For the cyclopamine experiments, embryos were treated
with 100 AM cyclopamine (Toronto Chemical) by adding 10
Al of 10 mM stock solution (in 100% EtOH) to 1 ml of egg
water (0.3 g/l Instant Ocean Salt, 1 mg/l methylene blue)
starting at the shield stage. Control embryos were treated
simultaneously with an equal volume of 100% EtOH
(cyclopamine carrier) in 1 ml egg water.
For mRNA injections, plasmid DNA was linearized with
the appropriate restriction enzyme, separated from uncutFig. 2. Developmental expression of zebrafish gli3. (A) RT–PCR analysis using gli
stage (prior to zygotic transcription), as well as at shield, tail bud, and 24-h stages,
expressed in neural ectoderm (arrowheads) with expression most intense in the
expressed throughout the brain and spinal cord (arrowheads) with expression being
Dorsal view. (D) gli3 is expressed throughout the embryonic brain and developin
midbrain and midbrain/hindbrain border (arrowheads). (E) In the trunk, gli3 is exp
tube formation (arrowheads). (F, G) Twelve-somite stage (15 h). (F) At 15 h,
diencephalon (arrow) in the forebrain. (G) At 15 h, gli3 is strongly expressed in
Eighteen-somite stage (17 h). (H) Dorsal expression of gli3 (purple/blue) is large
However, in the most anterior diencephalon (arrow in H), gli3 expression overlap
gli3 (purple) is expressed in the neural tube dorsal to shh (red), which is in the floo
is expressed weakly in the eye in cells surrounding the lens. (K–N) At 44 h. (K) At
dorsal diencephalon, hypothalamus, tectum, and dorsal hindbrain. Small clusters of
brain also expresses gli3 (arrow). (L) In the trunk, gli3 expression is restricted to th
(arrow). (M) Dorsal view of hindbrain showing two rows of ventral cells (see K
expressed throughout the fin bud with the exception of cells at the posterior margin
of shh (right panel). (B, C, F–H, J–K) Side views, anterior to the left. (D, E, M, N)
H) Eyes removed. Abbreviations: di; diencephalon, hb; hindbrain, hy; hypothalDNA by running an agarose gel electrophoresis, and
purified with GENECLEAN II KIT (BIO 101 Systems,
cat no. 1001-400). Synthetic mRNA was made using the
Message Machine kit (Ambion) and diluted in water to 0.5–
1 mg/ml. shh and control lacZ mRNAs were synthesized
from pT7TS plasmids containing shh (Ekker et al., 1995)
and lacZ (Karlstrom et al., 2003).
Cell culture analysis of transcriptional activity
Reporter assays were performed using the C17 neural cell
line (Snyder et al., 1992) and a C17 cell line stably transfected
with Shh-N (Feng et al., 2004). Twenty-four hours before
transfection, 8  104 cells per well were plated into 24-well
plates. Lipofectamine (Invitrogen) was used to transfect the
reporter (0.2 Ag 8 Gli-BS-luciferase; Sasaki et al., 1997),
Renilla luciferase-expressing internal control (25 ng pRL-
Null), and pcDNA constructs expressing Gli1, -2, -3, mutant
you-too ty119(Karlstrom et al., 1999), empty vector, or
combinations as indicated in the Fig. 7 legend. Luciferase
assays were performed 48 h after transfection using a dual-
luciferase assay kit (Promega). Transfection results were
normalized according to Renilla luciferase activity, per-
formed with an n of 6 and duplicated.Results
Sequence and developmental expression of zebrafish gli3
To better understand the in vivo function of vertebrate
Gli3, we cloned and characterized the gene encoding
zebrafish Gli3. Using a bacterial artificial chromosome
(BAC) genomic library and an embryonic cDNA library,
we identified several genomic and cDNA clones that
contained gli3-like sequences (see Materials and meth-
ods). One gli3-containing BAC was mapped to linkage
group 24 of the zebrafish genetic map by SSCP analysis.
A RACE reaction was used to clone the 5V end of3-specific primers shows that maternal gli3 mRNA is present at the four-cel
after zygotic transcription has begun. (B) Tail bud stage (10 h). gli3 is firs
brain. (C) Five-somite stage (12 h). During early somitogenesis, gli3 is
lost in more ventral neural tissue (arrow). (D, E) Seven-somite stage (13 h)
g eyes (arrows) with more intense stripes of expression in the presumptive
ressed in the spinal cord (arrow) and in the lateral neural plate prior to neura
gli3 is expressed throughout the telencephalon (arrowhead) and anterio
the spinal cord and is restricted to the dorsal neural tube (arrows). (H, I
ly complementary to the more ventral expression of shh (red) in the brain
s with shh expression. (I) Cross-section through the spinal cord shows tha
r plate (arrow) and notochord. (J) At 30 h, lateral view of dissected eye. gli3
later stages, gli3 expression becomes restricted to the anterior telencephalon
cells also express gli3 in the ventral hindbrain. Mesendoderm ventral to the
e most dorsal regions of the spinal cord (arrowheads) and ventral endoderm
for lateral view) on either side of the midline that express gli3. (N) gli3 is
(arrowhead). This expression overlaps with, but is much broader than, tha
dorsal views. (I) Cross-section through trunk. (D–L) Yolks removed. (D, F
amus, tb; tail bud, t; telencephalon, tec; tectum. l
t
.
l
r
)
.
t
,
t
,
O.V. Tyurina et al. / Developmental Biology 277 (2005) 537–556 543zebrafish gli3 and assemble a full-length cDNA of 4701
base pairs that encodes a protein of 1567 amino acids (aa)
(Fig. 1A). Sequence of this Gli protein is more similar to
mouse, human, and frog Gli3 than it is to zebrafish Gli1
and Gli2 (Fig. 1B). The N-terminal repressor domain (aa
1–397) (Dai et al., 1999; Sasaki et al., 1999) of zebrafish
Gli3 shows 80% similarity with mouse, human, and
Xenopus Gli3 proteins, and contains stretches of sequences
with over 80% identity with mGli3 (Fig. 1C). The C-terminal end of zfGli3 is less conserved, although the area
that encodes a putative activator domain (aa 827–1132)
(Dai et al., 1999) includes regions of more than 80%
identity with Gli3 proteins of other species as well as
zfGli1 and zfGli2 (Bai and Joyner, 2001; Ding et al., 1998;
Karlstrom et al., 2003; Matise et al., 1998).
Further evidence that this gene encodes zebrafish Gli3
comes from expression analysis. Similar to gli3 expres-
sion in other species, early gli3 expression overlaps with
Fig. 3. Hh signaling negatively regulates gli3 expression. (A) In 20-h wild-
type embryos, gli3 is expressed regionally in the dorsal neural tube, with
strong expression in the tectum and midbrain/hindbrain boundary (arrow-
heads). (B) gli3 expression is expanded ventrally in smu(smo) mutant
embryos that lack Hh pathway activity (arrows). (C) gli3 expression is
generally reduced in shh mRNA-injected wild-type embryos (compare to
lacZ mRNA-injected embryo in inset). (D) gli3MO injection also led to
severely reduced gli3 expression levels (compare to control MO-injected
wild-type embryo in inset). All panels show gli3 expression in 20-h
zebrafish embryos. Lateral views of head, anterior to the left, eyes and yolk
removed.
O.V. Tyurina et al. / Developmental Biology 277 (2005) 537–556544shh in all tissues examined, while later expression
becomes complementary to shh expression. RT–PCR
analysis showed that maternally derived gli3 mRNA is
present at the four-cell stage, prior to zygotic transcription
(Fig. 2A). Neural gli3 expression begins in the anterior
part of the embryo (future brain) at tail bud stage, about
10 h postfertilization (Fig. 2B). During early somito-
genesis, gli3 is expressed throughout the brain and eyes
(Figs. 2C, D), and later expression expands into the trunk
(Figs. 2C, E, G). At 15–17 h, gli3 is expressed in the
intermediate/dorsal regions of the embryonic brain (Figs.
2F, H). In the forebrain, gli3 expression extends more
ventrally (Figs. 2F, H), overlapping with shh expression
(Fig. 2H). In the trunk, gli3 is first expressed throughout
the neural plate and later becomes restricted to the dorsal
spinal cord (Figs. 2E, G, I). This pattern is similar to gli3
expression in mouse, chick, and frog (Lee et al., 1997;
Meyer and Roelink, 2003; Sasaki et al., 1997). In the eye,
gli3 is weakly expressed at 28–30 h in retinal ganglion
cells surrounding the lens (Fig. 2J). By 44 h, gli3
expression is restricted to the most dorsal neural tube
(Fig. 2L). In the forebrain, midbrain, and hindbrain, gli3
transcripts can be detected in small clusters of cells
throughout the brain (Figs. 2K, M), indicating a possible
role in differentiation of these cells. gli3 expression in the
fin bud begins around 37 h of development, and by 44 h,
gli3 is expressed uniformly throughout the fin bud with
expression in the posterior zone of polarizing activity
(ZPA) overlapping with shh (Fig. 2N). This gli3
expression pattern fits well with that of gli3 in other
species that have been reported (Lee et al., 1997; Sasaki
et al., 1997) and shows details of overlapping expression
not previously documented.
Transcriptional regulation of gli3 by Hh signaling
Using both mutant and misexpression analyses, we next
examined how gli3 transcription is regulated by Hh
signaling. We found that zebrafish gli3 is negatively
regulated by Hh signaling, similar to what has been
suggested for mouse and frog gli3 (Aoto et al., 2002;
Wang et al., 2000; Wijgerde et al., 2002). In embryos that
lack all Hh pathway activity [smu(smo) mutants] (Barresi
et al., 2000; Chen et al., 2001; Varga et al., 2001; Wijgerde
et al., 2002), gli3 expression is expanded ventrally (Fig.
3B). Similar expansion was also detected in syu(shh)
mutants (data not shown). Furthermore, ectopic Shh
expression led to reduced gli3 expression throughout the
embryo (Fig. 3C). To determine whether other Gli proteins
might regulate gli3 expression, we analyzed the expression
of gli3 in dtr(gli1) and yot(gli2) mutants, and in wild-type
embryos injected with gli1 and gli2 morpholino (MO)
antisense oligonucleotides (Karlstrom et al., 2003). gli3
expression was largely unaffected in dtr mutants and gli1
morphants, suggesting that Gli1 does not play a major role
in regulating gli3 expression (data not shown). Interest-ingly, gli2MO injections and the presence of a dominant
repressor form of Gli2 in yot(gli2) mutants have little or no
effect on gli3 expression (data not shown), indicating that
the Hh-dependent repression of gli3 in the ventral CNS is
not mediated by Gli2 repressor activity, even at earlier
ages when gli2 is expressed more ventrally in the neural
tube (Karlstrom et al., 1999, 2003).
Consistently, injections of gli1MO alone and together
with gli2MO also did not have any effect on gli3
expression (data not shown). This lack of gli3 transcrip-
tional regulation by Gli1 and Gli2 is similar to what was
seen in mouse Gli2/ and Gli1/;Gli2/ mice (Matise
et al., 1998). We also designed gli3-specific MOs (see
below) and examined the effect of reducing Gli3 function
on gli3 transcription. In contrast to Gli1 and Gli2, reducing
Gli3 function led to a loss of gli3 expression, suggesting
that Gli3 may positively regulate its own transcription
(Fig. 3D). While this is an attractive model, at this point,
we cannot rule out the possibility that the loss in gli3
mRNA in gli3MO-injected embryos is an artifact caused
by destabilization of gli3 mRNA upon MO binding.
However, since no other gli MO shows a similar effect
on its target message, mRNA destabilization does not
appear to be a general artifact of MO binding.
Together, these experiments show that zebrafish gli3
expression is negatively regulated by Hh signaling,
similar to mouse and chick gli3 (Aoto et al., 2002;
Wang et al., 2000; Wijgerde et al., 2002), but that this
regulation is independent of Gli1 and Gli2 activity. This
suggests that a transcription factor other than Gli2 and
Gli1 is involved in Hh-mediated repression of gli3
transcription.
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regulated and overlaps with Gli2 repressor function
To test the function of Gli3 during zebrafish embryo-
genesis, we designed two independent translation-blocking
morpholino antisense oligonucleotides. Both morpholinos
were effective based on changes in Hh target geneFig. 4. Temporally regulated Gli3 repression of the Hh target gene fkd4. (A, B, D
(A, B) and axial (D) in the ventral brain, medial floor plate, and lateral floor plate
and gli1 (inset) at 19 h (E) but had dorsally expanded fkd4 (F, U) and gli1 (F in
zebrafish Gli3. (C, G, T, V) smu(smo) mutant embryos had reduced fkd4 expressio
did not lead to dorsal expansion of fkd4 (G, V, arrowheads) indicating that acti
(Karlstrom et al., 2003), cyclopamine treatment starting at shield stage led to an
resulted in a dramatic increase in gli1 expression in cyclopamine-treated embryos
embryos (H), indicating target specificity for the Gli3 repressor. (I, J) gli2MO injec
at 19 h (I) or at 24 h (J). (K, L) In contrast, a few cells ectopically expressed fkd4 in
gli2MO injection, revealing a weak, Hh-independent, repressor function for Gli2. (
fkd4 in wild-type embryos at 24 h (N) but not 19 h (M), similar to single gli3MO
expression in a few dorsal neural cells in smu(smo) mutants at 24 h and expanded
injected wild-type embryos had dorsally expanded fkd4 expression at both 19 h (Q
that Shh signaling is capable of inducing fkd4 expression at both of these ages.
(arrowhead) floor plate cells. (T) In smu(smo) mutants, fkd4 is expressed only in th
gli3MO injection into wild-type embryos led to dorsally expanded fkd4 expression.
expression in lateral floor plate cells or expand fkd4 expression dorsally. (W) Sim
rescue fkd4 expression in lateral floor plate or expand fkd4 expression dorsally. (A–
left. (S–W) Cross-sections of the trunk region, anterior up.expression, but the MO designed to cover the translational
start site was most effective and was used for the majority of
experiments presented. Similar to what has been shown in
other vertebrates (Litingtung and Chiang, 2000; Meyer and
Roelink, 2003; Persson et al., 2002; Wijgerde et al., 2002),
we found that zebrafish Gli3 acts as a repressor of ventral
gene expression in the dorsal CNS. Reducing Gli3 func-) Control MO-injected wild-type embryos with normal expression of fkd4
. (E, F) gli3MO-injected wild-type embryos had normal expression of fkd4
set) expression at 24 h, revealing a temporally regulated repressor role for
n (C, T, arrowheads), and gli3MO injections into smu(smo) mutant embryos
ve Hh signaling is necessary for this expansion. As in smu(smo) mutants
extreme reduction of gli1 expression at 20 h (C inset). gli3MO injection
(G inset). (D, H) No expansion of axial was detected in gli3MO-injected
tion into wild-type embryos did not lead to expanded fkd4 expression either
smu(smo) mutants (K) and axial in wild-type embryos (L) (see insets) after
M, N) Coinjection of gli3MOs and gli2MOs resulted in dorsal expansion of
injections. (O) Double gli2MO + gli3MO injections also led to ectopic fkd4
axial expression (P), similar to gli2MO injections alone. (Q, R) shh RNA-
) and 24 h (R) compared to lacZ mRNA-injected embryos (inset), showing
(S) Cross-section shows fkd4 expression in the medial (arrow) and lateral
e medial floor plate (arrow) and is lost in lateral floor plate (arrowhead). (U)
(V) gli3MO injection into smu(smo) mutant embryos did not rescue of fkd4
ilarly, injection of gli3MOs and gli2MOs into smu(smo) mutants did not
R) Side views of zebrafish embryos, yolks and eyes removed, anterior to the
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lateral and medial floor plate marker fkd4 (Figs. 4F, U,
Table 1). This in vivo derepression of fkd4 expression
appears to depend on active Hh signaling, as no fkd4
expansion was seen in gli3MO-injected smu(smo) mutant
embryos (Figs. 4G, V).
A more careful temporal analysis demonstrated that this
expansion of fkd4 is developmentally regulated. While
gli3MO injection led to dorsal expression of fkd4 when
injected embryos were assayed at 24 h (Fig. 4F), no dorsal
expression was seen when assayed 5 h earlier at 19 h of
development (Fig. 4E, Table 1). In fact, at this earlier time
point, ventral fkd4 expression was slightly reduced in
gli3MO-injected embryos (Fig. 4E). To verify that dorsal
neural cells are competent to express fkd4 at both 19 and
24 h, we injected shh RNA into wild-type embryos and
analyzed fkd4 expression. Dorsal expansion of fkd4 was
detected at both 24 h (Fig. 4R, Table 1) and at 19 h (Fig. 4Q,
Table 1), verifying that cells are competent to respond to Hh
signaling at both of these time points. In addition, gli3 is
expressed in the dorsal neural tube at 19 h, a time when loss
of Gli3 function fails to expand fkd4 (see Figs. 2E–H). This
indicates that other factors restrict fkd4 expression to the
ventral neural tube prior to 24 h. We wondered whether Gli2
might be this earlier repressor; however, removing both Gli2
and Gli3 function led to little or no expansion of fkd4 at 19 h,
with more robust expansion seen at 24 h (Figs. 4M, N).
Since Gli1 is the main activator of Hh target genes in
zebrafish (Karlstrom et al., 2003), we wondered whether
expanded fkd4 expression in gli3MO-injected embryos
could be due to Gli1 activity. Indeed, gli3MO injections
led to expanded gli1 expression into the dorsal neural tube
at 24 h but not 19 h of development (insets in Figs. 4E, F,
Table 1). To directly test whether this expanded Gli1
expression is responsible for the dorsal expansion of fkd4
expression, we next injected gli3MOs into dtr(gli1) mutant
embryos. While fkd4 expansion was seen in wild-type
siblings, fkd4 expansion was not seen in gli3MO/dtr(gli1)
mutant embryos (Table 1). Thus, expansion of fkd4 in
gli3MO-injected embryos appears to be mediated by
dorsally expanded gli1 expression. We next examined
whether Gli3-mediated repression of gli1 transcription
required Hh signaling activity. In this case, we blocked
Smo-mediated Hh signaling using the alkaloid drug cyclop-
amine (CyA) (Incardona et al., 1998; Taipale et al., 2000).
CyA treatment alone led to an extreme reduction of gli1
expression (Fig. 4C inset), similar to the situation in
smu(smo) mutants (Karlstrom et al., 2003). In contrast,
injection of gli3MOs resulted in a dramatic increase in gli1
expression in CyA-treated embryos (compare Fig. 4C and G
insets, Table 1), indicating that inhibition of gli1 tran-
scription by Gli3 does not require Hh activity. Thus, Gli3 is
acting as an Hh-independent repressor, similar to Droso-
phila Ci. Given the lack of fkd4 expansion in gli3MO-
injected smu(smo) mutant embryos (Fig. 4G), we conclude
that expanded expression of gli1 is not sufficient in itself forthe activation of Hh targets, but that Gli1 requires active Hh
signaling to induce fkd4 and presumably other Hh target
genes.
In mouse embryos, the balance between Shh signaling
and Gli3 repression was shown to pattern the neural tube
(Litingtung and Chiang, 2000; Meyer and Roelink, 2003;
Persson et al., 2002; Wijgerde et al., 2002). In Shh/;
Gli3/ double mutant mice, ventral neural cell types that
are absent in Shh/ single mutants are partially restored
(Litingtung and Chiang, 2000; Meyer and Roelink, 2003).
This shows that Shh signaling is not necessary for the
differentiation of some ventral cell types in the absence of
Gli3 and implies that a major function of Hh signaling is to
overcome Gli3 repression of ventral fates. To determine
whether ventral cell types can form in the absence of both
Hh and Gli3 function in zebrafish, we injected gli3MOs into
smu(smo) mutants that lack Hh signaling activity. In
smu(smo) mutants, fkd4-expressing lateral floor plate cells
are missing, while fkd4-expressing medial floor plate cells
are present either because they do not require Hh signaling
activity to differentiate or due to maternal smo expression
(Fig. 4T, Varga et al., 2001). Similar to the situation in
mouse, differentiation of the most ventral cell types (fkd4-
expressing lateral floor plate cells) was not rescued in
gli3MO/smu/(smo) embryos (Fig. 4V, Table 1). Unlike
the situation in mouse, motoneuron differentiation, as
assayed by isl-2 expression, was not restored by injecting
gli3MOs into smu(smo) mutants (data not shown).
In the trunk, gli3 expression largely overlaps with gli2
(Fig. 2 and Karlstrom et al., 1999). Since zebrafish Gli2 can
also repress Hh target genes (Karlstrom et al., 2003), we
wondered whether loss of both Gli2 and Gli3 function could
rescue ventral cell types in smu(smo) mutants. Again, no
rescue of fkd4-expressing lateral floor plate cells or isl-2-
expressing motoneurons was seen in gli2MO/gli3MO/
smu/(smo) embryos (Fig. 4W), consistent with the idea
that differentiation of these ventral cell types requires Gli1-
mediated Hh signaling.
Interestingly, blocking Gli2 synthesis in smu(smo)
mutants led to expanded fkd4 expression in some dorsal
hindbrain (Fig. 4K, Table 1) and spinal cord (not shown)
cells, but had no effect on wild-type embryos (Figs. 4I, J,
Table 1). Coinjections of gli3MO and gli2MO into the
progeny of smu(smo) heterozygous parents led to dorsal
fkd4 expression in 37/60 wild-type and heterozygous
embryos (43% of total injected embryos) (Fig. 4N, Table
1) and dorsal expression of fkd4 in just a few cells in 8/26
mutants (9% of total injected embryos) (Fig. 4O, Table 1).
These data show that Gli2 acts as a weak repressor in the
dorsal hindbrain and spinal cord.
These experiments also uncovered an activator function
for Gli2 in the ventral midbrain. In the midbrain, fkd4
expression is eliminated after gli2MO injection into
smu(smo) mutant embryos (Fig. 4K, arrowhead), indicating
that Gli2 is needed for activation of this gene in this
region, consistent with the earlier ventral expression of
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activator of Hh signaling in the ventral CNS (Karlstrom
et al., 2003).
We also analyzed other Hh target genes expressed in the
floor plate, including nk2.2 and axial. To our surprise,
expression of these markers did not expand in embryos
injected with gli3MOs (Fig. 4H, Table 1 and data not
shown). In combination with the fact that shh mRNA
injection is capable of inducing nk2.2 and axial expression
(Hauptmann and Gerster, 1996), this suggests that Gli3
repression is not equivalent for all Hh target genes. One
possibility is that our MO experiments do not completely
block Gli3 function and that some Gli3 protein remains that
is capable of repressing some but not all ventral genes. This
model would suggest that Gli3 repression is more potent for
some genes than others. Another possibility is that yet
another Gli protein may act as a repressor of Hh targets in
the caudal brain and spinal cord, and that the combination of
Gli repressor activities leads to target-specific regulation.
Indeed, in 10% of gli2MO- or gli2MO/gli3MO-injected
embryos, axial expression was detected in a few cells in the
dorsal neural tube (Figs. 4L, P, Table 1), suggesting a weak
repressor role for Gli2 in regulating axial expression. InFig. 5. Positive regulation of nk2.2 and ptc1 expression by Gli3 and Gli1. (A) Wi
dtr(gli1) mutants nk2.2, expression is regionally absent (arrows). (C) smu(smo) m
decreased nk2.2 expression in wild-type embryos (D) and further reduced nk2.2 e
gli1MO produced a smu(smo)-like phenotype with no nk2.2 expression. (G) ptc1 e
had little or no effect on ptc1 expression. (I) gli1MO injections reduced expressio
almost completely. (A–F) lateral views of 19-h embryos, eyes and yolks removed,
yolks removed.either event, our data show that Gli3 and Gli2 repressor
activities appear to be different for different target genes.
In summary, we have shown that the requirement for
Gli3 repression of ventral gene expression is temporally
regulated and that Gli2 and Gli3 have partially overlapping
repressor functions that differ at different axial levels of the
neural tube.
Gli3 functions with Gli1 to activate ventral Hh target genes
in the neural tube
To determine whether Gli3 also has a function as an
activator of Hh signaling, we next examined the effect of
gli3 knockdown on Hh target genes expressed in the ventral
neural tube. As mentioned above, gli3MO injections led to a
reproducible but mild reduction in ventral fkd4 expression
in the midbrain and hindbrain (Fig. 4E) and nk2.2
expression in the forebrain (Fig. 5D, Table 2), consistent
with a weak activator function for Gli3. The fact that gli1
and gli3 expression initially overlap in the CNS prompted
us to determine whether these two genes might functionally
overlap in activation of the Hh response. To block both Gli1
and Gli3 function, we injected gli3MOs into dtr(gli1)ld-type nk2.2 expression in a control MO-injected zebrafish embryo. (B) In
utants have no nk2.2 expression at 19 h. (D, E) gli3MO injections generally
xpression in dtr(gli1) mutants (E, arrows). (F) Coinjections of gli3MO and
xpression was not affected by control MO injections. (H) gli3MO injections
n of ptc1. (J) Coinjection of gli3MO and gli1MO reduced ptc1 expression
anterior to the left. (G–J) Dorsal views of 11-h embryos, anterior to the left,
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expression is regionally absent (Fig. 5B and Karlstrom et al.,
2003)). Injections of gli3MO into dtr(gli1)/ embryos
further reduced nk2.2 expression (Fig. 5E, Table 2), and in
some embryos, nk2.2 expression was completely absent,
similar to the phenotype caused by the complete loss of Hh
signaling in smu(smo) mutants (compare Figs. 5C and F,
Table 2). These results show that Gli3 and Gli1 have
overlapping activator functions in the forebrain. We next
examined the effect of reducing Gli1 and Gli3 function on
the expression of the Hh target gene ptc1. Injection of
gli1MO alone led to a minor general reduction in ptc1
transcription (Fig. 5I), while gli3MO injections had little or
no effect on ptc1 expression (Fig. 5H). This is in contrast to
the mild increase in ptc1 expression seen after gli2MO
injections (Karlstrom et al., 2003). Depletion of both Gli3
and Gli1 proteins led to a stronger reduction of ptc1
expression than that seen in any single MO injection (Fig.
5J, Table 2), consistent with overlapping activator roles for
Gli1 and Gli3.
The data above demonstrate that Gli1 and Gli3 have
overlapping activator functions in the zebrafish ventral
neural tube. In mouse, similar overlapping functions for
Gli1 and Gli2 were demonstrated to be dosage-dependent
(Park et al., 2000). To test whether the combined dosage of
Gli1 and Gli3 is important for Hh target activation, we
injected gli3MOs into dtr(gli1) heterozygous individuals
and examined diencephalic expression of the Hh target gene
nk2.1b (Rohr et al., 2001). Injection of gli3MOs into
progeny of two dtr(gli1)+/ heterozygous parents produced
embryos that could be divided into three groups based on
nk2.1b expression levels: (1) mildly reduced nk2.1b
expression was detected in approximately 25% of embryos
(presumed dtr(gli1)+/+), corresponding to the reduction seen
after gli3MO injection into known wild-type embryos (Figs.
6A, D), (2) a dtr(gli1)/ homozygous mutant-like reduc-
tion in nk2.1b expression was detected in 50% of the
embryos, corresponding to dtr+/ heterozygotes (Figs. 6B,
E), (3) a dramatic reduction of nk2.1b expression resem-
bling that seen in smu(smo)/ mutants was detected in
25% of the embryos, corresponding to gli3MO-injected
dtr(gli1)/ homozygous mutants (Figs. 6C, F, see graph).
Thus, while loss of one copy of Gli1 in dtr(gli1)+/
heterozygotes had no effect on nk2.1b expression levels,
reduction of Gli3 function in these same embryos led to
reduced Hh signaling.
In contrast to this effect on diencephalic nk2.1b
expression, reducing Gli3 function had little or no effect
on nk2.1b expression in the telencephalon (arrows in Figs.
6D, E, F). We previously showed that Gli2 represses nk2.1b
expression in the telencephalon (Karlstrom et al., 2003).
Since the repressor functions of Gli3 and Gli2 overlap in the
neural tube, we decided to test if they also overlap in the
telencephalon. In embryos coinjected with gli3MO and
gli2MOs, nk2.1b expression was expanded in the telen-
cephalon to the same level as seen in embryos injected onlywith gli2MOs (Karlstrom et al., 2003). In the diencephalon,
gli2MO + gli3MO injections reduced nk2.1b expression to
the levels seen after single gli3MO injection (arrowheads in
Figs. 6G, H, I). Together, these data indicate that Gli2 and
Gli3 do not have overlapping or opposing functions in the
forebrain.
Shh regulates Gli3 repressor and activator function in a
neural cell line
To further test how zebrafish Gli3 protein functions in
relation to Shh and Gli1, we turned to a neural cell culture
assay for Gli transcriptional activity (Karlstrom et al., 2003;
Sasaki et al., 1997). Consistent with the late repressor
function shown above for Gli3 in vivo, we found that
zebrafish Gli3 reduced reporter activation by Gli1 in the
absence of high levels of Shh (Figs. 7A, B). This is
consistent with the repressor role shown for mouse and
human Gli3 proteins (Sasaki et al., 1997, 1999). To
determine whether the presence of Shh affects Gli3
function, we next repeated these reporter assays using a
stably transfected cell line that expresses high levels of Shh
(Feng et al., 2004). In the presence of Shh, Gli3 showed no
activator function on its own (Fig. 7C). However, in the
presence of Shh, Gli3 increased the ability of Gli1 to
activate the Gli-responsive reporter construct (Fig. 7D).
These results show that in the presence of Hh signaling,
Gli3 can work with Gli1 to activate Hh target gene
expression. The fact that Gli3 showed no activator function
in the absence of Gli1 (Fig. 7C) indicates that this activator
function depends on Gli1, as shown in mouse (Bai et al.,
2004). These data are consistent with our in vivo data
showing early and overlapping activator roles for Gli3 and
Gli1 in the ventral neural tube, close to the source of Hh.
Gli3 and retinal ganglion cell differentiation
Hh signaling is required for differentiation of retinal
ganglion cells (RGCs) in the developing eye, with a wave of
Hh expression directing RGC differentiation starting at 28–
30 h of development (Neumann and Nuesslein-Volhard,
2000). This wave of cell differentiation requires ath5 (Kay
et al., 2001), a zebrafish homolog of the basic helix–loop–
helix transcription factor atonal, which in turn requires Hh-
mediated signaling, most likely from the midline (Masai et
al., 2000; Stenkamp and Frey, 2003). The gli genes
responsible for the activation of this Hh response in the
eye have not been identified. Gli1 and Gli2 are not required
in this process, as RGC differentiation is largely unaffected
in dtr(gli1) and yot(gli2DR) mutant embryos (Karlstrom et
al., 1996). We noticed that gli3 is expressed in the eye at
approximately the ages when RGC differentiation begins
(Fig. 2J, data not shown) and wondered whether Gli3 might
mediate this Hh-dependent differentiation event. To test this,
we injected gli3MOs into wild-type embryos and assayed
the differentiation of RGCs at 40 h and ath5 expression at
Fig. 6. Regulation of nk2.1b expression by Gli3, Gli1, and Gli2. (A) nk2.1b expression in the forebrain is identical in wild-type and dtr(gli1)+/ heterozygous
embryos. (B) dtr(gli1)/ mutants have reduced nk2.1b expression in the dorsal diencephalon adjacent to the telencephalon (arrowhead). (C) smu(smo) mutant
with greatly reduced nk2.1b expression in both the telencephalon and diencephalon. (D, E, F) gli3MO (10 ng) injected into a clutch of embryos from
dtr(gli1)+/ heterozygous parents yielded 6 (26%) wild-type embryos which had a slight reduction of nk2.1b in the dorsal diencephalon (D, arrowhead), 10
(44%) heterozygous dtr(gli1)+/ embryos which had a dtr(gli1) mutant-like loss of nk2.1b expression in the dorsal diencephalon (E, arrowhead), and 7 (30%)
dtr(gli1)/ mutant embryos which had greatly reduced diencephalic nk2.1b expression (F, arrowhead) similar to phenotype seen in smu(smo) mutants.
(G, H, I) Coinjection of gli3MOs and gli2MOs into a clutch of embryos from dtr(gli1)+/ heterozygous parents resulted in a slight reduction of diencephalic
nk2.1b expression in 6 (25%) embryos (G, arrowhead), a dtr(gli1)/ mutant-like reduction of nk2.1b expression in 12 (50%) embryos (dtr(gli1)+/
heterozygotes) (H, arrowhead), and greatly reduced diencephalic nk2.1b expression in 6 (25%) embryos (dtr(gli1)/ mutants) (I, arrowhead). Double MO
injections led to dorsal expansion of nk2.1b in the telencephalon (arrows in G, H, I), as shown previously for gli2MOs (Karlstrom et al., 2003). All panels show
30-h embryos, side views of the forebrain, eyes and yolk removed, anterior to the left. Genotype was determined by comparing defects in marker gene
expression. (J) Graph showing percentages of injected embryos with different nk2.1b expression patterns.
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in RGC differentiation. In the most severely affected
embryos (approximately 23% of injected embryos), only a
few ZN-5-labeled RGC cell bodies were present in the eye,
and these were distributed in abnormal locations (Fig. 8B,Table 2). Less severely affected embryos (approximately
38%) had reduced RGC numbers, with RGCs being
patterned normally and extending axons correctly across
the midline to form a thin optic nerve and chiasm (Fig. 8C,
Table 2). These differences in defect severity are likely due
Fig. 7. Transcriptional activity of zebrafish Gli1, Gli2, and Gli3 in C17 neuronal cells. (A–D) pcDNA constructs encoding zebrafish Gli1, Gli2, Gli3, and the
yotty119 Gli2-dominant repressor (Gli2-DR) (Karlstrom et al., 2003) proteins were transfected into C17 cells along with a luciferase reporter gene under the
transcriptional control of eight Gli1 binding sites (Sasaki et al., 1997). (A) In the absence of Shh, Gli1 (but not Gli2 or Gli3) can activate the reporter in a dose-
dependent manner. (B) Cotransfection of multiple gli constructs in the absence of Shh shows that Gli2, truncated Gli2 proteins encoded by zebrafish you-too
mutants, and Gli3 can all repress Gli1-mediated transcriptional activity. (C, D) The same experiments were performed in a cell line stably expressing Shh (Feng
et al., 2004). (C) In the presence of Shh, Gli1 activator function is largely unaltered, and Gli2 and Gli3 do not activate the reporter construct. (D) In the presence
of Shh, Gli3 expression enhances rather than represses Gli1-mediated reporter gene expression.
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later stages of development (28 h) when Hh expression
begins to induce RGC differentiation in the eye (Neumann
and Nuesslein-Volhard, 2000). The fact that RGC axons can
cross the midline in embryos with extremely reduced RGC
numbers suggests that midline guidance cues are expressed
normally in the absence of Gli3 function at the midline. This
is contrast to zebrafish Gli1 and Gli2, which are both
involved in the formation of the diencephalic substrate for
RGC axon growth (Karlstrom et al., 1999, 2003).
To determine whether the wave of cell differentiation
caused by Hh signaling is initiated in the absence of Gli3
function, we examined the expression of ath5 in gli3MO-
injected embryos. Again, two classes of affected embryos
were seen, with the severity of response being MO dose-
dependent (Table 1). At higher doses of gli3MO (12 ng),
ath5 expression in the eye was completely eliminated in
over 60% of injected embryos and severely reduced in 30%
of embryos (Fig. 8E, Table 2). Since ath5 expression and
RGC differentiation are known to depend on Hh signaling
(Kay et al., 2001; Masai et al., 2000; Neumann and
Nuesslein-Volhard, 2000; Stenkamp and Frey, 2003) andsince RGC differentiation is normal in zebrafish, gli1
and gli2 mutants and morphants (Karlstrom et al., 1996
and R.O.K. unpublished data), we conclude that gli3 is the
primary activator of Hh-mediated RGC differentiation in the
developing eye.Discussion
Dual roles for zebrafish Gli3 in activating and repressing
Hh signals
We demonstrate that zebrafish Gli3 acts as both an Hh-
dependent activator and an Hh-independent repressor in Hh
signaling, functions that are conserved between mammals
and fish. Early in development, Gli3 is an activator,
combining with Gli1 to help pattern the ventral CNS.
Consistent with this in vivo function, in vitro reporter assay
analyses show that Gli3 cooperates with Gli1 in the
presence of Hh to activate target gene transcription. Gli3
activator function is also required in the eye for the
differentiation and patterning of retinal ganglion cells. We
Fig. 8. Gli3 is required for RGC differentiation. (A) At 40 h of development, large numbers of Zn-5 labeled retinal ganglion cells (RGCs) (arrowheads) in the
eyes have differentiated and extended axons across the midline to form the optic nerve and chiasm (arrow). (B) In severely affected gli3MO injected embryos,
very few RGCs differentiated, and those that were present were distributed aberrantly in the eye (arrowheads). (C) In less severely affected gli3MO injected
embryos, reduced numbers of RGCs differentiated in the correct location and extended axons across the midline to form a thin optic nerve and chiasm (arrow).
(D) At 34 h, the zebrafish atonal homolog ath5 is expressed throughout the central region of the differentiating retina. (E) In severely affected gli3MO-injected
embryos, ath5 expression was completely eliminated in the eye. (F) In less severely affected gli3MO-injected embryos, ath5 expression was strongly reduced.
(A–C) Fluorescent labeling of RGCs at 40 h using the Zn-5 antibody, ventral views of head, anterior up. (D–F) ath5 in situ labeling of the eyes at 34 h, lateral
views of the left eye, dorsal up, anterior to the left.
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Gli3 becomes required to repress expression of some but not
all ventral Hh target genes. Consistent with a repressor role
in tissues distant from the source of Hh, our in vitro analysis
confirms that zebrafish Gli3 inhibits Gli1-mediated gene
activation in the absence of Hh. Our data suggest that Gli3
blocks Hh target gene expression in part by restricting
expression of Gli1, itself an Hh target gene, to the ventral
neural tube.
Vertebrate Gli3 proteins as activators of Hh signaling
While Gli3 has been widely studied as a repressor of Hh
signaling, several lines of evidence have recently come
together to show that gli3 can activate Hh signaling duringvertebrate embryogenesis. First, cell culture analyses show
that full-length Gli3 can activate a reporter construct
containing Gli1 binding sites (Dai et al., 1999). In addition,
ectopic expression of N-terminally truncated forms of Gli3
shows that the Gli3 protein can activate Hh target genes in
vivo (Ruiz i Altaba, 1998; Sasaki et al., 1999). These in
vitro/ectopic expression results have recently been comple-
mented by in vivo evidence for Gli3 activator function. The
fact that Gli2/;Gli3+/ double mutant mice have more
severe skeletal, lung, and tracheal defects than Gli2/
mutants suggests overlapping activator functions for these
two Gli proteins (Mo et al., 1997; Motoyama et al., 1998).
Additionally, recent epistasis analyses of the Ptc, Gli2, and
Gli3 mutations in mouse show that Gli3 can activate the Hh
response to help pattern the ventral neural tube (Motoyama
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gli2 locus demonstrated that Gli3 can rescue some ventral
spinal cord defects seen in Gli2 mutant mice, and that Gli3
acts as a Gli1-dependent activator of the Hh response (Bai et
al., 2004).
Our double knockdown analysis has now shown that
zebrafish Gli3 functions, in combination with Gli1, to help
pattern the ventral neural tube. This Gli3 activator function is
weaker than that of Gli1, as loss of Hh target genes is not seen
when only Gli3 function is blocked. This is similar to the
situation in mouse, where Gli3 activator function is weaker
than that of Gli2, the primary activator inmammals (Bai et al.,
2004). Our data show that the role of Gli3 as a secondary
activator of Hh signaling has been evolutionarily conserved.
Gli3 cooperates with Gli1 in the presence of Shh
Our in vitro reporter assay also provides new evidence
that zebrafish Gli3 cooperates with Gli1 to activate Hh
target genes. In the absence of Gli1, Gli3 shows no activator
function in the C17 neuronal line. However, in the presence
of Gli1, Gli3 promotes Gli1 activation of the reporter
construct in an Shh-dependent manner. Human Gli3 was
previously shown to activate a similar reporter construct in
NIH3T3 and MNS70 cell lines, with Hh enhancing this
activity while suppressing cleavage of Gli3 protein (Dai et
al., 1999). Expression of Gli1 was not needed to see Gli3
activator function in these cells, and cooperativity with Gli1
was not examined. How can we explain the Hh and Gli1
dependence of Gli3 activity in C17 cells? A likely
explanation for Hh dependence is that the processed
repressor form of Gli3 predominates in C17 cells, and that
Hh is needed to block this processing. It has been shown
that Gli1 and Gli3 can bind the same DNA sequences in
vitro (Ruppert et al., 1990; Sasaki et al., 1997; Vortkamp et
al., 1995), suggesting that both proteins could be activating
the reporter gene through the same promoter sequences.
However, if Gli1 and Gli3 were simply binding to the same
sequence, we would expect Gli3 alone to activate the Hh
response. The fact that no activation is seen in C17 neuronal
cells suggests that ectopically expressed Gli3 may be
efficiently processed to a repressor form. The increased
activation of the Gli reporter upon cotransfection of Gli1
and Gli3 suggests a cooperative interaction between Gli3
and Gli1 proteins resulting in enhanced activator function.
The fact that cooperativity is seen only in cells transfected
with Hh indicates that Hh is needed to confer this activator
function on Gli3. Based on the known mechanisms by
which Hh regulates Gli3 in vitro (Dai, 1999), this could
occur by inhibition of cleavage and/or by activity enhancing
modifications of the full-length protein.
Gli3 and retinal ganglion cell differentiation
Our studies have also uncovered a new role for gli3 in
the differentiation of retinal ganglion cells in the eye. MOinhibition of Gli3 function led to a loss in ath5 expression, a
reduction in RGC numbers, and disrupted RGC organiza-
tion in the eye. Hh signaling has been shown to be required
for the wave of RGC and other cell differentiation in the eye
(Neumann and Nuesslein-Volhard, 2000; Stenkamp and
Frey, 2003), but it was not known which Gli protein was
responsible for mediating this differentiation program. Our
data indicate that Gli3 is the primary activator of Hh-
mediated RGC differentiation in the eye, since we have
previously shown that RGC differentiation is apparently
normal in both gli1(dtr) and gli2(yot) mutant embryos
(Karlstrom et al., 1996). The midline may be the original
source of Hh signals that induces the first RGCs to
differentiate (Masai et al., 2000; Stenkamp and Frey,
2003), with later (28–30h) eye-specific expression of Shh
serving to propagate RGC differentiation as the eye
develops (Neumann and Nuesslein-Volhard, 2000). ath5
expression begins in the choroid fissure at approximately
25 h of development and spreads into the retina by 25 h
(Masai et al., 2000), and ath5 expression can be completely
eliminated following injection of gli3MOs (Fig. 8E).
gli3 expression begins to be detected in the RGC layer at
26–30 h of development (Fig. 2J), suggesting that gli3
expression in the eye could mediate this early ath5
response. In addition, an increase in gli3 expression in
RGCs at 30 h indicates that gli3 transcription may be up-
regulated by Hh in these cells, consistent with a role in
activating the Hh response. Whether Gli3 plays a role in
later Hh-dependent retinal cell differentiation (Shkumatava
et al., 2004) remains to be investigated.
Gli3 repressor activity: temporal regulation
A large amount of in vivo and in vitro data support a
major role for Gli3 as a repressor of Hh signaling
(reviewed in Ingham and McMahon, 2001). What remains
unclear is exactly how this repressor function is spatially
and temporally regulated in vivo. Our results demonstrate
that the requirement for Gli3 repression in the hindbrain
and spinal cord varies at different times in embryogenesis,
with Gli3 being required to repress fkd4 and gli1
expression in the dorsal neural tube at 24 h, but not at
19 h of embryonic development (Fig. 4). Furthermore, we
show that gli3 is expressed in the neural tube at both ages
and that fkd4 can expand dorsally at 19 h in shh mRNA-
injected embryos, indicating that Gli3 is present and cells
are capable of ectopically expressing Hh genes at the
earlier age. How then is fkd4 expression restricted to
ventral cells at early ages? One obvious possibility is that
another Gli protein, most likely Gli2, acts as the primary
repressor at early stages. However, reducing both Gli2
and Gli3 function did not lead to ectopic fkd4 expression
at 19 h. This may indicate that yet another Gli repressor
may be involved in the early repression of Hh targets in
the dorsal CNS. A fourth Gli-like sequence has been
reported with expression similar to Gli2 that may perform
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How could Gli3 activate Hh signaling early in develop-
ment but then repress Hh signaling at later ages? One
possibility is that temporally regulated posttranslational
processing of Gli3 may occur between these ages. While
it remains to be shown that Gli3 is cleaved in the embryonic
nervous system, several studies suggest that Gli3 repressor
function is the result of a cleavage event that creates a
truncated protein similar to the Ci repressor isoform (Dai et
al., 1999; Shin et al., 1999). Indeed, it was demonstrated
that human and mouse Gli3 proteins undergo cleavage to
produce C-terminal repressors of Hh signaling when
expressed in the fly wing imaginal disc (Aza-Blanc et al.,
2000). Consistently, a truncated repressor form has been
observed in cell culture assays (Ruiz i Altaba, 1999), and in
mouse and chick limbs (Wang et al., 2000). In the mouse,
analyses of Shh/ and Shh/;Gli3/ mutants demon-
strated that Gli3 acts as a repressor in the absence of Hh
signaling (Rallu et al., 2002). Our results raise the
possibility that this cleavage could be temporally regulated.
Combinatorial Gli repressor functions
We found that Gli3 function is needed to repress fkd4
expression but not to repress the floor plate markers nk2.2 and
axial (Fig. 4). Since Shh is known to regulate the expression
of these genes, we predicted that another Gli protein must
counteract Hh signaling in order to restrict nk2.2 and axial to
the ventral CNS. Since gli3 and gli2 expression patterns
overlap in the neural tube (Fig. 2 and Karlstrom et al., 1999)
and since Gli2 acts as a repressor in the telencephalon
(Karlstrom et al., 2003), we examined whether Gli2 could be
this second repressor. We found that Gli2 does indeed
contribute to the repression of axial in the dorsal neural tube
(Fig. 4L). Previous findings also indicate that Gli proteins can
differentially regulate the expression of different Hh targets
(Aza-Blanc et al., 2000; Mullor et al., 2001).
Unlike mouse where loss of Gli3 repressor function
partially rescues the Shh/ phenotype (Litingtung and
Chiang, 2000; Meyer and Roelink, 2003), loss of both Gli3
and Gli2 repressor functions in zebrafish embryos lacking
Hh signaling activity [smu(smo) mutants] does not rescue
lateral floor plate or motor neuron defects (Fig. 4O, Tables
1,2). Thus, repression of gli3 by Hh is not sufficient for
ventral spinal cord development in zebrafish as it is in mice.
This could be because Gli1-mediated Hh signaling is
directly needed for ventral differentiation. Alternatively, a
Gli protein other than Gli2 and Gli3 may act to block Hh
target gene expression in the dorsal neural tube.
Regulatory interactions among gli genes
The expression patterns of the different gli genes help
define distinct cellular responses to Hh signals. Initially, all
three gli genes are expressed in most regions of the CNS,with expression becoming refined so that repressor glis (gli2
and gli3) are expressed more dorsally, while expression of
the primary activator gli (gli1) remains ventral. The
presence of gli3 transcripts prior to gli1 and hh expression
in frog animal caps, mouse and chick limb buds, and quail
somites is consistent with an initial activator role for Gli3 in
regulation of Gli1 in these tissues (Borycki et al., 2000; Lee
et al., 1997). As in other species, expression of zebrafish
gli3 initially overlaps with shh and gli1 in ventral neural
tissue, consistent with their initial overlapping activator
functions. The subsequent loss of gli3 expression ventrally
appears to be a direct result of Hh signaling, as loss of Hh
signaling leads to a ventral expansion of gli3, while ectopic
expression of Hh represses gli3 expression throughout the
neural tube (Fig. 3).
Our observation that gli3MO injection leads to a loss of
gli3 transcripts dorsally was surprising and suggests that Gli3
could positively regulate its own transcription, perhaps by
inhibiting the transcription of another repressor. This would
provide a feedback mechanism that might explain the later
expression pattern. In this model, early Hh-independent gli3
expression in the ventral neural tube would be repressed by
Hh signals, while dorsal expression of gli3 would directly or
indirectly act to maintain gli3 transcription there.
Our finding that gli1 expression expands dorsally in
gli3MO-injected embryos (Fig. 4F) indicates that gli1 is
itself a target of Gli3 transcriptional repression. The fact that
this gli1 expansion occurs in CyA-treated gli3MO-injected
embryos (Fig. 4G) indicates that, like Drosophila Ci, Gli3
repression of Hh target genes is Hh-independent. Reducing
Gli3 function does not completely restore normal levels of
gli1 in CyA-treated embryos, however, confirming that
normal gli1 expression levels require active Hh signaling.
The final level of gli1 expression in the zebrafish neural
tube can thus be seen to result from a balance between Hh-
dependent activation and Hh-independent Gli3-mediated
repression, similar to the situation in mouse (Litingtung and
Chiang, 2000; Meyer and Roelink, 2003). In the absence of
Hh signals (CyA-treated and smu(smo) embryos), Gli3
repressor function predominates, resulting in a nearly
complete repression of gli1 expression (Fig. 4C). Since
gli3 is expressed broadly in the developing spinal cord (with
the exception of the most ventral region, see Fig. 2H), this
can partially explain the ventrally restricted gli1 expression
pattern; under normal conditions, Gli3 repression keeps gli1
levels low except in the ventral cells that are exposed to Hh.
The balance of Hh-dependent Gli1 activator and Hh-
independent Gli3 repressor activities along the dorsal/
ventral axis of the neural tube would ultimately result in
graded expression of gli1 activator function, contributing to
a graded morphogen response.
Species-specific differences in Gli3 function
A major challenge in understanding Hh signaling is to
determine how vertebrate Gli transcription factors work
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vertebrate species examined, Gli1 seems to be primarily an
activator of the Hh transcriptional response, while Gli2 and
Gli3 can have both activator and repressor functions.
Despite this conservation, Gli genes also have evolved
distinct functions in different species. We previously
showed that Gli1 is the major activator of Hh signaling in
zebrafish, whereas Gli2 has minor activator and repressor
roles that are tissue- and region-specific (Karlstrom et al.,
2003). This contrasts with the situation in mouse, where
Gli2 is the major activator of the ventral Hh response and
Gli1 functions as a minor activator that is not essential for
initial neural patterning. The dual roles of Gli3 as both a
weak activator and repressor of Hh signaling seem to be
conserved among vertebrate species. Besides similarities in
function, we found that the transcription of gli3 is regulated
by Hh in a way that is similar to that in mouse (Fig. 3, Ruiz i
Altaba, 1998; Wang et al., 2000). Thus, Gli3 is conserved as
a complex, bifunctional transcriptional regulator of Hh
target genes whose function is regulated at multiple levels,
and in distinct ways in different tissues and at different
developmental stages. Given that both gain-of-function and
loss-of-function Hh signaling mutations lead to human
disease, it is important to understand the rules governing Gli
combinatorial function across different species.Acknowledgments
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